tirzepatide compound news today Compounding pharmacies can resume making as FDA reconsiders shortage ๐จ BREAKING COMPOUND GLP-1 NEWS
Description
Understanding which foods to avoid and what to eat helps optimize both results and comfort
The good news is, per the FDAs assessment, that tirzepatide and semaglutide are no longer in short supply
Check provider credentials
Both the SURMOUNT and The SURPASS clinical trials examined the effects of Tirzepatide in thousands of patients, demonstrating its safety and clinically significant benefits (2, 4)
doi: 10.2337/dc20-2151 53 FDA News release
